Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis

Abstract Background Anti-neutrophil cytoplasmic antibodies associated vasculitides (AAV) are characterized by autoimmune small vessel inflammation. Eosinophils are multifunctional cells with both pro-inflammatory and immunoregulatory properties. Tissue activated eosinophils secrete cyto- and chemoki...

Full description

Bibliographic Details
Main Authors:	Thomas Hellmark, Sophie Ohlsson, Åsa Pettersson, Markus Hansson, Åsa C. M. Johansson
Format:	Article
Language:	English
Published:	BMC 2019-03-01
Series:	BMC Rheumatology
Subjects:	ANCA Systemic vasculitis Eosinophils Reactive oxygen species Granulomatosis with polyangiitis Microscopic polyangiitis
Online Access:	http://link.springer.com/article/10.1186/s41927-019-0059-6

Similar Items

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
by: T V Beketova
Published: (2018-05-01)

Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California
by: Deepika Singh, et al.
Published: (2023-07-01)

Update of Management of ANCA-Associated Vasculitis
by: Hoi San Tang, et al.
Published: (2021-12-01)

Natural Killer Cells in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - A Review of the Literature
by: Sina Fuchs, et al.
Published: (2022-01-01)

A Candidate Gene Approach to ANCA-Associated Vasculitis Reveals Links to the C3 and CTLA-4 Genes but not to the IL1-Ra And Fcγ-RIIa Genes
by: Ulf Persson, et al.
Published: (2013-12-01)

Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment
by: Arman F, et al.
Published: (2018-11-01)

Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis
by: Jun Ishizaki, et al.
Published: (2017-09-01)

CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF ANCA-ASSOCIATED VASCULITIS: 7 YEARS OF EXPERIENCE IN DIAGNOSIS AND TREATMENT
by: L. M. Kudelya, et al.
Published: (2020-03-01)

Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis
by: Kazuyuki Tsuboi, et al.
Published: (2022-10-01)

Primary Vasculitis in Childhood: GPA and MPA in Childhood
by: Mehul P. Jariwala, et al.
Published: (2018-08-01)

CLINICAL AND LABORATORY FEATURES OF ANCA ASSOCIATED VASCULITIS: EXPERIENCE AT A TERTIARY CARE HOSPITAL IN LAHORE, PAKISTAN
by: Muhammad Zeeshan Aslam, et al.
Published: (2021-02-01)

Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis
by: Alexandre Wagner Silva de Souza, et al.

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
by: Megan M. Sullivan, et al.
Published: (2024-01-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
by: Robson JC, et al.
Published: (2018-01-01)

The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic
by: T. V. Beketova, et al.
Published: (2021-03-01)

THE 2016 EUROPEAN (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS
by: T. V. Beketova
Published: (2017-03-01)

Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study
by: Alicia Rodriguez-Pla, et al.
Published: (2021-04-01)

Granulomatosis with polyangiitis: An atypical initial presentation
by: Catarina Vilaça Pereira, et al.
Published: (2022-01-01)

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
by: Dario Roccatello, et al.
Published: (2022-03-01)

Multiple Cutaneous Manifestations in ANCA-Positive Eosinophilic Granulomatosis with Polyangiitis before and after Biologic Therapy: Clinical and Histopathologic Characterization of a Paradigmatic Case
by: Giorgia Carnicelli, et al.
Published: (2022-12-01)

Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature
by: Spoerl David, et al.
Published: (2012-12-01)

Endobronchial Lesion in Eosinophilic Granulomatosis with Polyangiitis
by: Guan-Liang Chen, et al.
Published: (2017-12-01)

Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis
by: Jang Woo Ha, et al.
Published: (2023-12-01)

Clinical characteristics and long-term survival differences of the ANCA-associated vasculitis group: a cross-sectional study of 27 patients
by: Jolanta Dadonienė, et al.
Published: (2017-07-01)

CLINICAL AND LABORATORY FEATURES OF ANCA ASSOCIATED VASCULITIS: EXPERIENCE AT A TERTIARY CARE HOSPITAL IN LAHORE, PAKISTAN
by: Muhammad Zeeshan Aslam, et al.
Published: (2021-02-01)

Ophthalmological involement and laboratory changes in patients with ANCA-associated vasculitis and polyarteritis nodosa
by: O. Iaremenko, et al.
Published: (2022-12-01)

Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides
by: Peter Lamprecht, et al.
Published: (2018-04-01)

Classification of systemic vasculitis: evolution from eponyms to modern criteria
by: Nikolay M. Bulanov, et al.
Published: (2022-06-01)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
by: Jamie R. Felzer, et al.
Published: (2022-01-01)

Granulomatosis with polyangiitis: a 17 year experience from a tertiary care hospital in Pakistan
by: Omar Irfan, et al.
Published: (2018-05-01)

Predictors of relapse in granulomatosis with polyangiitis: a multi-center study
by: Sara Safari, et al.
Published: (2022-10-01)

Severe mononeuritis multiplex in a patient with eosinophilic granulomatosis with polyangiitis
by: Desislava Kalinova, et al.
Published: (2019-10-01)

RUSSIAN EXPERIENCE WITH USING MONOCLONAL ANTIBODIES TO B-LYMPHOCYTES (RITUXIMAB) IN SYSTEMIC VASCULITIDES ASSOCIATED WITH NEUTROPHIL CYTOPLASMIC ANTIBODIES (PRELIMINARY RESULTS OF THE RUSSIAN REGISTER NORMA)
by: T. V. Beketova, et al.
Published: (2014-06-01)

Granulomаtosis With Polyangiitis Affecting the Lung and Orbit
by: Zh. V. Sheikh, et al.
Published: (2021-06-01)

Idiopathic Eosinophilic Vasculitis: Case Presentation and Literature Review
by: Adi Broyde, et al.
Published: (2023-04-01)

Individualization of the ANCA associated vasculitis treatment
by: Zbigniew Zdrojewski
Published: (2014-09-01)

Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies
by: Adél Molnár, et al.
Published: (2022-06-01)

Eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome) as a differential diagnosis of hypereosinophilic syndromes
by: Yuri Albuquerque Pessoa Santos, et al.
Published: (2017-01-01)

ANCA negative eosinophilic granulomatosis with polyangiitis (EGPA) presenting with left ventricular thrombus: An appreciation of distinct phenotypes and eosinophilic driven pathogenesis
by: Kai Chaivannacoopt, et al.
Published: (2022-10-01)